Adverse effects of glucocorticoids: coagulopathy

Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis

(2014) Linnéa Eriksson et al.   Cardiovascular Diabetology

Rotation thromboelastometry and the hypercoagulable state in Cushing's syndrome

(2014) Maria Caroline Alves Coelho et al.   CLINICAL ENDOCRINOLOGY

Blood coagulation and fibrinolysis in patients with Cushing’s syndrome: Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels

(2014) C. Erem et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Perioperative thromboprophylaxis in Cushing’s disease: What we did and what we are doing?

(2014) Mattia Barbot et al.   Pituitary

Multisystem Morbidity and Mortality in Cushing's Syndrome: A Cohort Study

(2013) Olaf M. Dekkers et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Role of insulin resistance in endothelial dysfunction

(2013) Ranganath Muniyappa et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Use of Glucocorticoids and Risk of Venous Thromboembolism

(2013) Sigrun A. Johannesdottir et al.   JAMA Internal Medicine

Hypercoagulable state in Cushing's syndrome is reversible following remission

(2012) Darko Kastelan et al.   CLINICAL ENDOCRINOLOGY

The Hypercoagulable State in Cushing's Disease Is Associated with Increased Levels of Procoagulant Factors and Impaired Fibrinolysis, But Is Not Reversible after Short-Term Biochemical Remission Induced by Medical Therapy

(2012) R. van der Pas et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Venous thromboembolism in patients with Cushing’s syndrome: need of a careful investigation of the prothrombotic risk profile

(2012) S. Koutroumpi et al.   Pituitary

Role of Lipotoxicity in Endothelial Dysfunction

(2012) Jeong-a Kim et al.   Heart Failure Clinics

Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction

(2011) Matthias Barton et al.   BRITISH JOURNAL OF PHARMACOLOGY

Incidence of Venous Thromboembolism in Patients with Cushing's Syndrome: A Multicenter Cohort Study

(2011) D. J. F. Stuijver et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

New Insight into the Hypercoagulability of Cushing’s Syndrome

(2011) Viviana Daidone et al.   NEUROENDOCRINOLOGY

Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery

(2010) Luca Manetti et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Mortality and Morbidity in Cushing's Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature

(2010) R. N. Clayton et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Basic mechanisms and pathogenesis of venous thrombosis

(2009) Charles T. Esmon   BLOOD REVIEWS

Should we evaluate for cardiovascular disease in patients with Cushing’s syndrome?

(2009) Francesco Fallo et al.   CLINICAL ENDOCRINOLOGY

Hypercoagulable State in Cushing’s Syndrome: A Systematic Review

(2009) Bregje Van Zaane et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis

(2009) Panagiotis Anagnostis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM